Showing 1 - 6 of 6
Lift antiviral drug curbs
News, Editorial, Published on 08/08/2022
» With new cases of Covid-19 having risen to more than 28,000 a day, and with soaring severe cases, restricted access to Covid-19 antiviral medicines is now a critical issue.
Managing Covid drugs
Oped, Editorial, Published on 01/04/2022
» Record Covid cases and ongoing reports of sluggish management of Covid medicine stock might derail the government's ambitious plans to list Covid-19 as endemic on July 1.
Act now on favipiravir
Oped, Editorial, Published on 04/08/2021
» Access to medicine can make a life-and-death difference amid the Covid-19 emergency. The government cannot afford to fail in the crucial mission of securing enough of the antiviral medication favipiravir to cover the rapid increase of patients.
Public needs antiviral meds
Oped, Editorial, Published on 01/05/2021
» Amid the Covid-19 pandemic, Thais have been gripped by fear. For months, these worries -- which have been intensified during the kingdom's third wave of infections -- have been about the government's slow vaccination rollout. Now the public is getting more anxious, following concerns over a possible shortage of favipiravir, an important medicine used to treat Covid-19 patients with moderate to severe symptoms.
'Tampon tax' no laughing matter
News, Editorial, Published on 22/12/2019
» No sooner had Puea Chat spokeswoman Ketpreeya Kaewsanmuang raised the issue of high taxes on tampons than she was in trouble. Prime Minister Prayut Chan-o-cha and Digital Economy and Society Minister Buddhipongse Punnakanta, seized by anger, lambasted her information as "fake news" and vowed legal action, but stopped short of attempting to make any actual sense of the matter.
Patients deserve better
News, Editorial, Published on 28/12/2018
» The government's plan to put medical supplies and medical service charges on the state price control list in order to deal with price gouging is a long-overdue effort that should be completed in no time.